These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7378141)

  • 1. Intravesical therapy with adriamycin in patients with superficial bladder tumors.
    Edsmyr F; Berlin T; Boman J; Duchek M; Esposti PL; Gustafsson H; Wijkström H; Collste LG
    Eur Urol; 1980; 6(3):132-6. PubMed ID: 7378141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical instillation with adriamycin + tween 80 in patients with superficial bladder tumors: a preliminary report.
    Eksborg S; Edsmyr F; Näslund I
    Eur Urol; 1982; 8(4):213-5. PubMed ID: 7094962
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravesical doxorubicin hydrochloride in the management of carcinoma in situ of the bladder.
    Jakse G; Hofstädter F
    Eur Urol; 1980; 6(2):103-6. PubMed ID: 7358059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical doxorubicin for prophylaxis in the management of recurrent superficial bladder carcinoma.
    Garnick MB; Schade D; Israel M; Maxwell B; Richie JP
    J Urol; 1984 Jan; 131(1):43-6. PubMed ID: 6690745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical therapy with adriamycin in urothelial dysplasia and early carcinoma in situ.
    Glashan RW; Riley A
    Can J Surg; 1982 Jan; 25(1):30-2. PubMed ID: 7055761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological grading of carcinoma in situ of the bladder: its clinical significance in patients who underwent intravesical mitomycin C and doxorubicin sequential therapy.
    Sekine H; Fukui I; Yamada T; Yamada T; Kojima S; Ohshima H
    J Urol; 1996 Jan; 155(1):94-8; discussion 98-9. PubMed ID: 7490908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical doxorubicin hydrochloride therapy for carcinoma in situ of the bladder: a followup.
    Jakse G; Hofstädter F; Marberger H
    J Urol; 1984 Jan; 131(1):41-2. PubMed ID: 6690744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?].
    Kriegmair M; Waidelich R; Baumgartner R; Lumper W; Ehsan A; Hofstetter A
    Urologe A; 1994 Jul; 33(4):276-80. PubMed ID: 7941172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical cisplatin for superficial bladder tumors.
    Blumenreich MS; Needles B; Yagoda A; Sogani P; Grabstald H; Whitmore WF
    Cancer; 1982 Sep; 50(5):863-5. PubMed ID: 7201343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracavitary doxorubicin hydrochloride treatment for carcinoma in situ of the urinary bladder. A comparative study of two therapy regimens.
    Jakse G
    Eur Urol; 1981; 7(2):68-72. PubMed ID: 7461006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical adriamycin therapy in carcinoma in situ of the urinary bladder.
    Ek A; Hellsten S; Henrikson H; Idwall I; Lindholm CE; Lindholm K; Mikulowski P; Månsson W
    Scand J Urol Nephrol; 1984; 18(2):131-4. PubMed ID: 6463596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine bladder biopsy after bacille Calmette-Guérin treatment: is it necessary?
    Skemp NM; Fernandes ET
    Urology; 2002 Feb; 59(2):224-6. PubMed ID: 11834390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitomycin C in multiple superficial bladder tumors: short-term therapy, long-term results.
    Milani C; Bassi P; Meneghini A; Garbeglio A; Zattoni F; Piazza N; Maruzzi D; Drago-Ferrante GL; Pagano F
    Urol Int; 1992; 48(2):154-6. PubMed ID: 1585510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adriamycin instillations in carcinoma in situ of the bladder].
    Edsmyr F; Anderson L; Esposti PL
    Urologe A; 1983 Sep; 22 Suppl():337-41. PubMed ID: 6685384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracavitary doxorubicin hydrochloride therapy for carcinoma in situ of the bladder.
    Jakse G; Hofstädter F; Marberger H
    J Urol; 1981 Feb; 125(2):185-90. PubMed ID: 7206051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of carcinoma in situ of the bladder with doxorubicin (adriamycin).
    Glashan RW
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S35-7. PubMed ID: 6640833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer.
    Solsona E; Iborra I; Dumont R; Rubio-Briones J; Casanova J; Almenar S
    J Urol; 2000 Sep; 164(3 Pt 1):685-9. PubMed ID: 10953125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome in carcinoma in situ of bladder treated with intravesical bacille Calmette-Guérin.
    Harland SJ; Charig CR; Highman W; Parkinson MC; Riddle PR
    Br J Urol; 1992 Sep; 70(3):271-5. PubMed ID: 1422687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa.
    Mobley WC; Loening SA; Narayana AS; Culp DA
    Urology; 1986 Apr; 27(4):335-9. PubMed ID: 3083555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.